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ABSTRACT
Analysis of genomic data is often complicated by the presence of missing values, which may arise due to
cost or other reasons. The prevailing approach of single imputation is generally invalid if the imputation
model is misspecified. In this article, we propose a robust score statistic based on imputed data for testing
the association between a phenotype and a genomic variable with (partially) missing values. We fit a
semiparametric regression model for the genomic variable against an arbitrary function of the linear
predictor in the phenotype model and impute each missing value by its estimated posterior expectation.
We show that the score statistic with such imputed values is asymptotically unbiased under general missing-
data mechanisms, even when the imputation model is misspecified. We develop a spline-based method to
estimate the semiparametric imputation model and derive the asymptotic distribution of the correspond-
ing score statistic with a consistent variance estimator using sieve approximation theory and empirical
process theory. The proposed test is computationally feasible regardless of the number of independent
variables in the imputation model. We demonstrate the advantages of the proposed method over existing
methods through extensive simulation studies and provide an application to a major cancer genomics











Recent technological advances have made it possible to
measure multiple genomics platforms on the same set of
subjects. However, constraints regarding cost and other
factors prohibit measurement of all platforms on all study
subjects. For example, in The Cancer Genome Atlas (TCGA)
(https://cancergenome.nih.gov/), over 10,000 subjects with 33
cancer types were measured on multiple genomics platforms,
including somatic mutation, copy number variation, and
expressions of microRNA, mRNA, and protein, but for a
substantial number of subjects, data on RNA sequencing and
protein expressions were not generated. As another example,
in the National Heart, Lung, and Blood Institute’s Exome
Sequencing Project (https://esp.gs.washington.edu/), only 7000
subjects with specific diseases or conditions were selected for
whole-exome sequencing from the tens of thousands of total
subjects with genotyping array data (Lin, Zeng, and Tang 2013).
Finally, in the Trans-Omics for Precision Medicine (TOPMed)
program (https://www.nhlbi.nih.gov/research/resources/nhlbi-
precision-medicine-initiative/topmed) and the Genome Sequenc-
ing Program (GSP; http://gsp-hg.org), whole-genome sequenc-
ing data will be available on hundreds of thousands of subjects,
but other genomics platforms, such as RNA sequencing,
methylation, and metabolites, will be available for only a few
thousand subjects through ancillary studies of specific diseases.
It is desirable to infer missing data on one genomics platform
using available data from other platforms. Indeed, this has
become a routine practice with genotype data, where linkage
disequilibrium allows one to impute, with great accuracy,
sequencing data from genotyping array data (Li et al. 2010;
Auer et al. 2012). A far greater challenge is to infer missing
values for a quantitative measurement, such as the expression of
RNA or protein, from other quantitative measurements or from
SNP genotype data due to the complex and noisy relationships
among those variables (Kim, Golub, and Park 2005; Torres-
García et al. 2009).
Several authors have considered missing data in the context
of association testing, which is of primary interest in genomics
studies. Specifically, Hu et al. (2015) studied the score test based
on imputed genotype data and proposed a variance estima-
tor that properly accounts for the differential quality between
observed and imputed genotypes. The method requires that the
imputation is unbiased and the genotype is independent of the
other variables in the phenotype model. Derkach, Lawless, and
Sun (2015) and Lawless (2018) proposed to model the variable
with missing values under outcome-dependent sampling and
studied the score test based on the full likelihood. Derkach,
Lawless, and Sun (2015) assumed a nonparametric model for
the variable with missing values and restricted covariates to only
a few possible values. Lawless (2018) assumed a full paramet-
ric missing-data model. All existing methods require unbiased
imputation or correct modeling of the variable with missing
values. This is difficult to achieve, especially when the number
of covariates in the missing-data model is not small.
In this article, we investigate the validity of the score test with
imputed data when the missing-data mechanism may depend
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on the phenotype and high-dimensional covariates. In particu-
lar, we show that a condition weaker than correct specification
of the missing-data model is sufficient for the score statistic to be
unbiased. Based on this finding, we propose a robust score test
which, unlike existing methods, preserves the Type I error under
general missing-data mechanisms even when the imputation
model is misspecified. The proposed score statistic is based on
a semiparametric model for the variable with missing values,
where covariates enter the model linearly and also through a
one-dimensional nonparametric function. As a result, the test
is feasible with a large number of covariates in the missing-data
model. The proposed methodology is applicable to all common
phenotype models and encompasses continuous, binary, and
right-censored phenotypes.
In Section 2, we formulate the problem, investigate the valid-
ity of the standard score test under various missing-data mecha-
nisms, and develop the robust score test. In Section 3, we report
results from simulation studies that compare the proposed and
existing methods. We provide an application to a dataset from
TCGA in Section 4 and make some concluding remarks in
Section 5.
2. Methods
Consider a genomics study that involves phenotype Y , genomic
variable of interest S, and vector of covariates X. For example, Y
may represent disease status, S may represent the RNA expres-
sion of a gene, and X may include genomic variables associated
with S, such as the mutation status and copy number of the
gene, or nongenomic variables, such as tumor stage, age, and
ancestry. Let f (·; βS + γ TX, ζ ) denote the density function of Y
conditional on (S, X), where β and γ are regression parameters,
and ζ is a set of nuisance parameters that may be infinite-
dimensional; this is referred to as the phenotype model. In
particular, ζ is the dispersion parameter in the generalized linear
model and the baseline hazard function in the proportional
hazards model. We allow S to be missing and let R indicate, by
values of 1 versus 0, whether S is observed or not, respectively.
Let Z be a set of predictors for S that includes X, as well as
variables that are not present in the phenotype model. The extra
variables in Z are exogenous variables that affect Y indirectly
through S and X, such that Z is independent of Y conditional on
X under β = 0. The observed data consist of (Yi, SiRi, Ri, Zi) for
i = 1, . . . , n.
We are interested in testing the null hypothesis H0 : β = 0.
Among the three common tests, namely, the Wald’s test, the
likelihood ratio test, and the score test, the first two require fit-
ting the model under the alternative hypothesis, which involves
estimation of the conditional distribution of S given X in the
presence of missing values for S. If the model for S is misspecified
(which is inevitable when the dimension of X is moderately
high), then the estimators of the nuisance parameters may be
inconsistent, such that the resulting tests are invalid. By contrast,
the score test only requires fitting the model under the null
hypothesis. As a result, the score test requires fewer assumptions
on the missing-data model than the other two tests to yield
correct Type I error. Therefore, we focus on the score test in the
rest of this article.
The score statistic for β at β = 0 takes the form of
A(Y , X; ψ)S, where A(Y , X; ψ) = ∂ log f (Y ; t+γ TX, ζ )/∂t |t=0,
and ψ = (γ , ζ ). Note that E{A(Y , X; ψ0) | X} = 0, where
ψ0 ≡ (γ 0, ζ 0) is the true value of ψ . This formulation includes
many common models as special cases. For the linear model,
A(Y , X; ψ) = σ−2(Y − γ TX), where σ 2 is the error variance.
For the logistic model, A(Y , X; ψ) = Y − eγ TX/(1 + eγ TX).
For the proportional hazards model with right censoring,
A(Y , X; ψ) =  − (T̃)eγ TX , where Y = (T̃, ), T̃ =
min(T, C),  = I(T ≤ C), T is the survival time of interest, C
is the censoring time, I(·) is the indicator function, and  is the
cumulative baseline hazard function.
We consider the score statistic based on the imputed S. We
specify an imputation model of S that depends on Z and a set of
parameters ξ . Let S̃(Zi; ξ̂) be the imputed value of Si, where ξ̂ is
an estimator of ξ . The (normalized) imputation “score” statistic
is
U impβ (ψ̂ , ξ̂) = n−1/2
n∑
i=1
A(Yi, Xi; ψ̂){RiSi + (1 − Ri)̃S(Zi; ξ̂)},
where ψ̂ ≡ (γ̂ , ζ̂ ) is an estimator of ψ under H0. At β = 0,
the score statistic based on the full likelihood with a regression
model of S on Z takes the form of U impβ . However, the proposed
imputation score statistic is more general in that S̃ needs not
be the posterior mean of S (given the observed data) evaluated
at the maximum likelihood estimator of ξ . Let ξ∗ be the limit
of ξ̂ . The following proposition provides a general sufficient
condition for the unbiasedness of the imputation score statistic
under H0.
Proposition 1. Assume that there exists a projection of X,
denoted by X̃, such that R is independent of (S, Z) conditional
on (Y , X̃) and E(S | γ T0 X, X̃) = E{̃S(Z; ξ∗) | γ T0 X, X̃}. Then,
E{U impβ (ψ0, ξ∗)} = 0 under β = 0.
The proofs of this proposition and other technical results are
provided in Section S.1 of the supplementary materials.
Remark 1. The missing-data mechanism assumed in this
proposition may arise from the extreme-tail sampling scheme,
where only subjects with extreme values of Y are selected for
measurements of S (Lin, Zeng, and Tang 2013). In this case, the
inverse probability weighting approach is not feasible because
P(R = 1 | Y) is zero for some subjects, whereas the imputation
approach is applicable.
Remark 2. The dependence of R on X̃ may be introduced
by design, where the sampling of S is performed separately at
different values of X̃. In cancer genomics, X̃ may include risk
factors such as tumor stage and tumor grade, and subjects with
unusually high or unusually low risk may be more likely to be
selected for measurements of S. In addition, X̃ may represent
categories defined by (possibly continuous) demographic vari-
ables such as age. Although X may be high-dimensional and
continuous, X̃ is typically a discrete, low-dimensional projection
of X, such that nonparametric modeling of S on X̃ is feasible.
Remark 3. The condition in Proposition 1 requires that the true
and imputed S variables have the same conditional expectation
given γ T0 X and X̃. This condition is trivially satisfied if S is
independent of X and the imputed value has the same mean as
S, as assumed by Hu et al. (2015). For the score statistic to be
unbiased, we only need the expectation of the true and imputed
S variables conditional on X̃ and a single index γ T0 X to be the
same. This is practically achievable via nonparametric model-
ing of S given the low-dimensional covariates (γ T0 X, X̃), even
though the whole set of covariates X may be high-dimensional.
If the missing-data mechanism does not depend on covariates,
then X̃ is absent, such that it is only necessary to correctly
model the conditional expectation of S given the single index
γ T0 X.
Proposition 1 implies that the imputation score statistic is
unbiased under H0 if the conditional expectation of S given
a specific projection of Z (but not necessarily the full set
of Z) is correctly specified. To guarantee that this condition
holds, we model the relationship between S and (γ T0 X, X̃)
nonparametrically when X̃ is discrete and takes a small number
of values. Because the regression model of S on (γ T0 X, X̃) may
not be very predictive, we include other components of Z in
the imputation model to improve the imputation accuracy.
Given the nonparametric function of (γ T0 X, X̃), the inclusion
of Z will not result in bias of the score statistic even if the
imputation model is misspecified. In the sequel, we assume that
the missing-data mechanism specified in Proposition 1 holds
and that X̃ is discrete with possible values (̃x1, . . . , x̃L). For each
x̃l (l = 1, . . . , L), we assume the working model E(S | Z, X̃ =
x̃l) = gl(γ T0 X)+ηTl Z̃, where gl is unspecified, and Z̃ is a specific
q-dimensional function of Z that is (asymptotically) orthogonal
to (γ T0 X, X̃). Let (g∗l , η
∗
l ) = arg min(gl ,ηl) E[R{S − gl(γ T0 X) −
ηTl Z̃}2
∣∣γ T0 X, X̃ = x̃l] almost surely, ξ = (g1, . . . , gL, η1, . . . , ηL),
and ξ∗ = (g∗1 , . . . , g∗L , η∗1, . . . , η∗L). The following proposition
states the unbiasedness of the resulting imputation score
statistic.
Proposition 2. If S̃(Z; ξ∗) = ∑Ll=1 I(X̃ = x̃l){g∗l (γ T0 X)+η∗Tl Z̃},
then E{U impβ (ψ0, ξ∗)} = 0.
Proposition 2 motivates us to estimate gl and ηl using least-
squares regression with the complete observations. We propose
to approximate gl (l = 1, . . . , L) with B-spline functions of order
m (De Boor 1978) and replace the true value γ 0 by the estimator
γ̂ . For simplicity of presentation, we assume the same set of fixed
B-spline functions for each gl, but we allow them to be chosen
adaptively and separately for each gl in practice. Let m and Kn
be integers, such that Kn ≥ m ≥ 2, and Kn depends on the
sample size n. For a set of grid points τ ≡ (τ0, . . . , τKn−m+1),
such that minX γ̂ TX = τ0 < · · · < τKn−m+1 = maxX γ̂ TX,
let B(·) = (B1(·), . . . , BKn(·))T, where Bk is the kth m-order
B-spline function on τ ; the grid points at the two ends have
multiplicity m. For l = 1, . . . , L, let












αlkBk(γ̂ TXi) − ηTl Z̃i
}2
,
where αl = (αl1, . . . , αlKn)T. Effectively, we partition the data
into L strata, with each stratum corresponding to a value of x̃l,
and we perform separate least-squares regression for each stra-
tum using subjects with observed S. Let α̂l = (̂αl1, . . . , α̂lKn)T,
ĝl = ∑Knk=1 α̂lkBk, and ξ̂ = (̂g1, . . . , ĝL, η̂1, . . . , η̂L). The robust
imputation score statistic is Urobβ (ψ̂ , ξ̂ ; γ̂ ), where









I(X̃i = x̃l){gl(γ TXi) + ηTl Z̃i}
]
,
and the third argument in Urobβ (ψ , ξ ; γ ) corresponds to γ in the
argument of gl.
Let 	β(ψ , ξ ; γ ) be Urobβ (ψ , ξ ; γ ) for a single subject,
	ψ(ψ)[h1] be the derivative of log f (Y ; γ TX, ζ ) along the
path ψ = ψ0 + εh1, with h1 being a tangent vector for ψ ,
	βψ(ψ , ξ ; γ )[h1] be the derivative of 	β(ψ , ξ ; γ ) along the
same path, 	ψψ(ψ)[h1, h2] be the derivative of 	ψ(ψ)[h1]
along the path ψ = ψ0 + εh2, with h2 being a tangent
vector for ψ , and 	ξ (ξ)[h3] be the derivative of R ∑Ll=1 I(X̃ =
x̃l){S − gl(γ T0 X) − ηTl Z̃}2/2 along the path ξ = ξ∗ + εh3,
with h3 being a tangent vector for ξ . Let Pn and P denote
the empirical and true probability measures, respectively. We
impose the following conditions.
(C1) For l = 1, . . . , L, g∗l and η∗l are unique, and g∗l has bounded
fourth derivative.
(C2) The support of Z is bounded, and γ T0 X has a bounded
continuous support. Conditional on Z, S has finite second
moment.
(C3) The number of knots of the B-spline functions is such that
K6nn−1/2 → 0 and K7nn−1/2 → ∞ as n → ∞.
(C4) At β = 0, ‖̂ζ − ζ 0‖ = op(n−1/4) for a suitable norm, and
the estimator γ̂ satisfies
γ̂ − γ 0 = Pn	∗γ (ψ0) + op(n−1/2),
where 	∗γ is the efficient score function of γ , such that
P	∗γ (ψ0) = 0, and P	∗γ (ψ0)	∗γ (ψ0)T is nonzero and finite.
(C5) The functions 	2β(ψ , ξ ; γ 0), 	
2
ψ(ψ)[h1], 	βψ(ψ , ξ ; γ 0)[h1],
and 	ψψ(ψ)[h1, h2] are Donsker for (ψ , ξ) belonging to
a neighborhood of (ψ0, ξ∗) and (h1, h2) belonging to a
bounded subset of a suitable metric space. In addition,
the information operator for the phenotype model
P	ψψ(ψ0)[·, ·] is invertible under the null hypothesis H0.
Remark 4. Conditions (C1) and (C2) pertain to regularity
conditions on the variable with missing values and covariates.
For g∗l and η
∗
l to be unique, we require that X̃ and γ
T
0 X cannot
be expressed as functions of linear terms of Z̃. In practice,
we let Z̃ be a linear combination of the components of Z not
present in X̃, such that
∑n
i=1 Z̃iZTi γ̂ = 0. Condition (C3)
pertains to the rate at which the number of knots of the B-
spline functions increases to infinity; particularly, the condition
is satisfied with Kn = O(n1/13). Conditions (C4) and (C5) are
regularity conditions on the phenotype model, which are satis-
fied for common models, such as generalized linear models and
proportional hazards models. For parametric models and the
Cox proportional hazards model, the norm in condition (C4) is
the Euclidean norm and the 	∞[0, t∗]-norm, respectively, where
t∗ is the end of the study, and the metric space for (h1, h2) in
condition (C5) is the Euclidean space and the space of functions
of bounded variation, respectively.
The asymptotic distribution of the robust imputation score
statistic is given in the following theorem.
Theorem 1. Under conditions (C1)–(C5) and β = 0,
Urobβ (ψ̂ , ξ̂ ; γ̂ ) is asymptotically zero-mean normal with variance
V = P[{	β(ψ0, ξ∗; γ 0) − 	ψ(ψ0)[hψ ] − 	ξ (ξ∗)[hξ ]
− Iγ (γ 0, ξ∗)T	∗γ (ψ0)}2],
where hψ solves P	βψ(ψ0, ξ∗; γ 0)[·] = P	ψψ(ψ0)[hψ , ·], hξ =
(hg,1 . . . , hg,L, hη,1, . . . , hη,L), such that hη,l = 0 and
hg,l(t) = E{(1 − R)I(X̃ = x̃l)A(Y , X; ψ0) | γ
T
0 X = t, X̃ = x̃l}
E{RI(X̃ = x̃l) | γ T0 X = t, X̃ = x̃l}
for l = 1, . . . , L,





I(X̃ = x̃l)X{Rg′l (γ TX)hg,l(γ TX)
− (1 − R)A(Y , X; ψ)gl′(γ TX)}
]
,
and f ′ denotes the first derivative of f for any function f .
Remark 5. The second and third terms in V are projections
of the score function of (ψ , ξ), and hψ is the least-favorable
direction of ψ for the phenotype model if the imputation model
is assumed to be known. The fourth term in V is present because
γ̂ , instead of the true value, is used in the imputation model. The
estimator γ̂ affects the imputation both by directly entering the
imputation function ĝl(γ̂ TX) and by involving in the estimation
of ĝl.
Motivated by Theorem 1, we propose an empirical variance





{	β ,i(ψ̂ , ξ̂ ; γ̂ ) − 	ψ ,i(ψ̂)[̂hψ ] − 	ξ ,i(̂ξ)[̂hξ ]
− Îγ (ψ̂ , ξ̂ )̂	∗γ (ψ̂)} − M
]2
,
where (	β ,i, 	ψ ,i, 	ξ ,i) is (	β , 	ψ , 	ξ ) evaluated at the observa-
tions of the ith subject, M is the sample mean of the term in the
curly brackets in V̂ , and (̂hψ , ĥξ , Îγ , 	̂
∗
γ ) is the empirical version
of (hψ , hξ , Iγ , 	∗γ ) evaluated at (ψ̂ , ξ̂). Specifically, ĥξ is obtained
by performing the usual linear expansion of ξ̂ at ξ∗, with the
imputation model treated as a linear model with covariates
I(X̃ = x̃l)(B(γ̂ TX)T, Z̃T)T. The explicit form of ĥξ is given in
the proof of Theorem 2 in Section S.1 of the supplementary
materials. We formulate the variance estimator under the linear
model, the logistic model, and the Cox proportional hazards
model in Section S.2 of the supplementary materials. The result-
ing score test statistic is Urobβ (ψ̂ , ξ̂ ; γ̂ )2/V̂ . The validity of the
robust score test is stated below.
Theorem 2. Under conditions (C1)–(C5) and β = 0, the empir-
ical variance estimator V̂ converges almost surely to the true
variance V , and the test statistic Urobβ (ψ̂ , ξ̂ ; γ̂ )
2/V̂ converges in
distribution to the chi-square distribution with one degree of
freedom.
Remark 6. The empirical variance estimator is consistent
regardless of the missing-data mechanism and the imputation
model. By contrast, the standard model-based variance estima-
tor with imputed data is generally biased if the missing-data
mechanism depends on the phenotype. The bias of the standard
variance estimator under generalized linear models is derived
in Section S.3 of the supplementary materials.
When the missing-data mechanism does not depend on the
phenotype, the score statistic is unbiased under any imputation
schemes; this result follows from the proof of Proposition 1. In
this case, the proposed test is not required for bias correction,
and one may wonder whether the inclusion of the B-spline terms
and the stratification may lead to power loss. The comparison
of power between the proposed test and the standard score test
under general settings is difficult, because the power generally
depends on the missing-data mechanism and high moments of
S; the derivation for the power of the proposed test is given in
Section S.4 of the supplementary materials. When Y is normally
distributed and S is missing completely at random, the asymp-
totic power of the proposed test is higher than or equal to that of
the standard score test, because the imputation model with the
B-spline terms, stratification, and linear predictors may have a
better fit than the model with the linear predictors alone.
3. Simulation Studies
Let X = (X1, X2, X3)T, where X1, X2, and X3 are independent
standard normal, Bernoulli(0.5), and Binomial(2, 0.25), respec-
tively. Let G be a vector of other covariates that are used to
predict S. In particular, G = (G1, . . . , G4)T, where Gj (j =
1, . . . , 4) is independent Binomial(2, 0.3). In cancer genomics,
X1, X2, and X3 may represent (standardized) age, gender, and
tumor stage, respectively, and G may represent genotypes at four
loci. We generated the phenotype Y using the linear predictor
r(S, X) = γ0 + γ TX +βS under the linear, logistic, and propor-
tional hazards models. For all models, we set γ = (1, −1, 0.5)T.
For the linear model, we generated Y ∼ N{r(S, X), 1} with γ0 =
0. For the logistic model, we set logit−1{P(Y = 1 | S, X)} =
r(S, X), where γ0 was chosen such that P(Y = 1) ≈ 0.15. For
the proportional hazards model, we generated Y with the hazard
function λ(t | S, X) = 0.5ter(S,X) and γ0 = 0. The censoring
variable was generated independently from Unif(0, τ), where
τ was chosen such that the censoring proportion was about
40%. We considered two models for S: with Model 1, S =
X1 + X2 + 0.3X3 + 0.4(G1 − G2 + G3 − G4) + N(0, 1); and
with Model 2, S = (X1 + X2) + 0.1(X1 + X2)2 + 0.3I(X3 =
2) + 0.4(G1 − G2 + G3 − G4) + N(0, 1).
We considered three missing-data mechanisms. Mechanism
1 is missing completely at random, where the missing-data
status is independent of other variables. For Mechanism 2, the
missing-data status was generated separately for two subsets
of subjects: one subset consisted of all subjects with X2 = 1,
and a random sample of subjects from the subset were selected
for observation of S; the other subset consisted of all subjects
with X2 = 0, and subjects from the subset were selected for
observation of S based on the phenotype. For the continuous
and survival phenotypes, an equal number of subjects at the two
extreme tails of the phenotype distribution were selected. For
the binary phenotype, all subjects with Y = 1 were selected,
and a fraction of subjects with Y = 0 were selected to attain
the desired missing proportion. The missing proportion was
set to be the same between the two subsets of subjects. This
setting mimics a study where two datasets with different sam-
pling schemes are combined. For Mechanism 3, four strata
were defined with X̃ ≡ ∑3j=0 I(X1 > zj/4) denoting the
stratum number, where zα is the α-quantile of the standard
normal distribution. Subjects were selected for observation of S
separately for each stratum using the sampling scheme adopted
for the second subset of subjects in Mechanism 2. The missing
proportion was set to be the same across strata. This setting
was designed to evaluate the sensitivity of the proposed test to
misspecification of X̃.
We compared the performance of six tests: (1) the standard
score test using complete data only; (2) the standard score test
with missing values imputed under a linear model of S on Z ≡
(XT, GT)T; (3) Lawless’s (2018) score test based on the same
model of S as (2); (4) Hu et al.’s (2015) score test with the
imputed data of (2); (5) the proposed score test with Z̃ being that
specified in Remark 4 and with stratification variable X̃ = X2 for
Mechanisms 1 and 2 or X̃ = I(X1 > 0) for Mechanism 3; and
(6) the imputation score test with missing data imputed using a
linear model of S on Z = (XT, X21, X1X2, I(X3 = 2), GT)T and
the empirical variance estimator. We refer to methods (1)–(6) as
the complete-case analysis, the simple imputation method, Law-
less’ method, Hu’s method, the proposed imputation method,
and the full-model imputation method, respectively. The last
method is the gold standard but is not practical because it
requires correct specification of a complex missing-data model.
Derkach, Lawless, and Sun’s (2015) method was not included
because it requires the covariates in the imputation model to
be discrete and is identical to Lawless’s (2018) method when
a linear imputation model is assumed. Note that the missing-
data models used by all the methods are correct under Model
1, but only the missing-data model used by the full-model
imputation method is correct under Model 2. For the proposed
imputation method, we chose the degree and number of knots of
the B-spline functions using five-fold cross-validation separately
for each stratum. For the lth stratum, the grid point τk (k =
1, . . . , Kn − m − 2) was set to be the empirical k/(Kn − m + 1)-
quantile of γ̂ TXi among subjects with Ri = 1 and Xi = x̃l,
τ0 = minX̃i=̃xl γ̂ TXi, and τKn−m−1 = maxX̃i=̃xl γ̂ TXi. Lawless’
and Hu’s methods are not applicable to the survival phenotype.
We considered a sample size of 1500 and missing propor-
tions ranging from 30% to 60%. For each setting, we simulated
1,000,000 and 100,000 replicates for β = 0 and β = 0,
respectively. The nominal significance level was set to 10−3. We
plot the rejection probability against the missing proportion for
the two models of S and the three missing-data mechanisms. For
reference, the rejection probability of the score test based on the
full data (i.e., no missing values) is also shown. For Mechanisms
1 and 2, the results of the linear model are displayed in Figure 1,
and the results of the logistic and Cox proportional hazards
models are displayed in Figures S1–S2 of the supplementary
materials. For Mechanism 3, the results are shown in Figures
S3–S5 of the supplementary materials.
Under Mechanism 1, all methods have correct Type I error.
Under Model 1 and Mechanism 2, the simple imputation
method has inflated Type I error because the variance of the
score statistic is underestimated. The complete-case analysis
is also invalid except for the binary phenotype, but the Type
I error inflation is not as severe; the complete-case analysis
for the binary phenotype has correct Type I error because of
the special structure of the logistic model (Prentice and Pyke
1979). Hu et al.’s (2015) variance estimator requires that both
the actual and imputed S variables are independent of X, which
does not hold under either Model 1 or Model 2. As a result, the
variance is overestimated under Mechanism 2, which leads to
Type I error deflation. The remaining methods have consistent
variance estimators and, therefore, have correct Type I error.
Under Model 2 and Mechanism 2, the score statistics of the
complete-case analysis and the methods based on a model of S
on linear terms of X are generally biased, giving rise to Type I
error inflation in most cases. Hu’s method exhibits Type I error
deflation under the logistic model because the bias of the score
statistic is offset by the overestimation of the variance in this
specific setting. (Because the absolute bias of the score statistic
tends to infinity as n → ∞, Hu’s method would yield Type
I error inflation for large enough sample size.) The proposed
imputation method is valid even though the imputation model
is misspecified because the score statistic is unbiased. The full-
model imputation method is also valid because the imputation
model is correct. Note that the proposed imputation method
and the full-model imputation method exhibit Type I error
deflation when the missing proportion is large. This is probably
because the two methods involve a relatively large number of
parameters, such that the normal approximations to the score
statistics are inaccurate when the effective sample size is small.
The power of the complete-case analysis is generally low
because it discards useful information. Under Model 1 or Mech-
anism 1, all valid methods that use the whole dataset have
similar power. Under Model 2 and Mechanism 2, the full-
model imputation method is the most powerful among the
valid methods because a correct imputation model is assumed.
However, this method cannot be used in practice because it
requires knowledge of the true relationship between S and Z.
The proposed imputation method is only slightly less powerful
than the full-model imputation method. The bias of the score
statistic of the other methods can lead to substantially low
power.
Under Mechanism 3, the proposed imputation method pre-
serves the Type I error even though X̃ is misspecified. The
simple imputation method underestimates the variance of the
score statistic and thus yields inflated Type I error, whereas
Hu’s method overestimates the variance and thus yields deflated
Type I error. For all phenotypes and models of S, the power of
the proposed imputation method is similar to or higher than
that of the other valid methods. Under Model 2 and the binary
phenotype model, Lawless’ and Hu’s methods yield substantially
lower power than the proposed imputation method due to the
bias of the model-based score statistic. These results suggest that
Figure 1. Rejection probabilities for the continuous phenotype under the null and alternative hypotheses for Mechanisms 1 and 2.
the proposed test is robust against misspecification of X̃, so that
strata with too few data points can be collapsed.
4. Real Data Analysis
We analyzed a dataset of patients with serous ovarian cancer
from TCGA (The Cancer Genome Atlas Research Network
2011). In the study, most subjects had available genomic data,
including data on DNA copy number, somatic mutation, and
levels of expression of mRNA measured by microarray plat-
forms. Only a subset of subjects had enough tissue sample left
for RNA sequencing, which was introduced after the study had
begun. Demographic and clinical variables, including age at
diagnosis, tumor stage, tumor grade, time to tumor progression,
and time to death, were available for most subjects. The median
follow-up time was about 2.5 years, and roughly 30% of the
patients were lost to follow-up before tumor progression or
death. The data are available at http://gdac.broadinstitute.org/.
We focused on testing the association between mRNA
expression, measured by RNA sequencing, and progression-free
survival time. We used the fragments per kilobase of transcript
per million mapped reads values for the mRNA expression
variable. The number of transcripts with RNA sequencing data
was about 57,000. We considered a subset of 9068 genes that
were mutated in samples from more than five subjects. The
number of subjects with available mutation, copy number, and
clinical data was 407, approximately 30% of whom did not have
RNA sequencing data.
We fit the Cox model for progression-free survival and
included age, age squared, tumor stage, tumor grade, the
interaction between age and (dichotomized) tumor stage, and
the interaction between age and (dichotomized) tumor grade
as covariates. Because the missing-data status is significantly
associated with tumor stage (with a p-value of 4.83 × 10−6)
but not with the other covariates, we set the stratification
variable X̃ to be (dichotomized) tumor stage. The predictors
in the imputation model of the RNA sequencing data included
age, age squared, somatic mutation, copy number, and mRNA
microarray expression; tumor stage and tumor grade were not
included because their inclusion would render the estimation of
the imputation model unstable. Microarray mRNA expression
and somatic mutation were excluded from the imputation
model if they were missing or too sparse. The B-spline functions
were selected in the same way as in the simulation studies.
For comparison, we performed the standard score test with
only the complete cases and with the missing values imputed
under a linear model. For further illustration, we performed
the proposed test and the standard score test on the dataset
with the missing proportion increased to 60%, where the RNA
sequencing variables for subjects with intermediate survival or
censoring time were treated as missing. The quantile-quantile
plots are shown in Figure 2.
For the original dataset, the p-values from the proposed
method agree with the expectation that most gene expressions
are not associated with progression-free survival. The complete-
case analysis and the simple imputation method yielded
Figure 2. Quantile-quantile plots for the RNA-seq analysis of the TCGA ovarian cancer data. The left plot shows the results for the original data, and the right plot shows
the results with the missing proportion increased to 60%. The p-values are truncated at 10−10.
Table 1. Top genes in the RNA-seq analysis of the TCGA ovarian cancer data.
Proposed Complete Simple
Gene method cases imputation Reference
WDR91 1.60E−05 3.20E−04 2.65E−05 N/A
SLC4A8 1.06E−04 7.77E−05 1.08E−05 N/A
SCEL 3.82E−04 8.86E−04 6.29E−03 N/A
DUSP1 6.73E−04 1.26E−03 2.63E−03 Denkert et al. (2002)
VMO1 7.94E−04 9.06E−02 4.24E−03 N/A
PDLIM3 9.25E−04 1.15E−02 3.19E−03 Mougeot et al. (2006)
Bignotti et al. (2007)
PLAUR 9.87E−04 5.38E−03 9.40E−04 Arend et al. (2013)
DCN 9.98E−04 1.67E−02 2.40E−03 Sherman-Baust et al. (2003)
CNTN4 1.22E−03 1.22E−01 1.32E−02 de Cristofaro et al. (2016)
MARK3 1.38E−03 2.53E−03 3.80E−04 N/A
NOTE: The top 10 genes identified by the proposed method are given in the first column, and their p-values under the proposed method, the complete-case analysis, and
the simple imputation method are given in the second to fourth columns. The references for studies that have identified an association between each gene and ovarian
cancer, if available, are given in the last column. “N/A” means that no prior studies that identified such an association can be found.
excessive false-positive signals because the standard variance
estimates of the score statistic are smaller than the empirical
variance. With extra missing data, the inflation of Type I error
is more severe for the simple imputation method, whereas the
Type I error is preserved by the proposed method.
The top 10 genes identified by the proposed method are
presented in Table 1. Several of them have been previously
known to be associated with ovarian cancer, with references
given in Table 1. Among these genes, the associations between
progression-free survival time and the expressions of all genes
except SLC4A8 are more significant under the proposed method
than under the complete-case analysis. The significance levels
for the associations between progression-free survival time and
the expressions of WDR91, SCEL, DUSP1, VMO1, PDLIM3,
DCN, CNTN4, and MARK3 are lower under the simple impu-
tation method than under the proposed method.
5. Discussion
In this article, we propose a robust score test for the association
between a phenotype and a genomic variable with partially
missing values. The test is based on a semiparametric model for
the genomic variable, where the semiparametric component
ensures that under the null hypothesis, the score statistic
with imputed values is unbiased for general missing-data
mechanisms and arbitrary distributions of the genomic variable.
Because each nonparametric function gl in the imputation
model is a one-dimensional function of the covariates, the
score test is computationally feasible with a large number of
covariates provided that L is small. In addition to correcting for
the bias of the score statistic, the semiparametric component
results in a better fit of the imputation model, which leads
to power gain even when data are missing completely at
random. When the missing-data mechanism depends on the
phenotype, the proposed test has correct Type I error, whereas
the standard score test is generally invalid. When the missing-
data mechanism is independent of the phenotype, both the
proposed and standard score tests have correct Type I error, but
the proposed test is asymptotically more powerful.
The validity of the proposed test follows from two spe-
cial properties of the score statistic under the null hypothesis.
First, the phenotype model does not involve the variable with
missing values, and the score statistic derived under the full
likelihood coincides with the imputation score statistic. Second,
the score statistic is mean zero if the expectations of the actual
and imputed values conditional on a low-dimensional function
of the covariates are equal. As a result, single imputation yields
a valid score statistic if the expectation of the variable with
missing values conditional on the low-dimensional function of
the covariates is correctly specified. These two properties do
not hold under the alternative hypothesis, making parameter
estimation with missing data a much more challenging problem
than hypothesis testing. For estimation, single imputation gen-
erally yields underestimation of standard errors (Little 1992),
and a correct specification of the missing-data model is required
for valid inference.
Multiple imputation (Rubin 1987) is an alternative to single
imputation. To perform multiple imputation, the distribution of
S conditional on the observed data, including the phenotype,
has to be correctly specified. By contrast, correct specification
of the distribution of S given a low-dimensional function of the
covariate X is sufficient for the proposed test to be valid. Thus,
multiple imputation requires much stronger assumptions than
the proposed test. In fact, multiple imputation with the missing
values imputed from the (correct) conditional distribution of S
given X is invalid (Little 1992).
Our work can be extended in several directions. First, we
have focused on a continuous genomic variable that is either
exactly observed or missing. We may allow for a binary or cat-
egorical variable by incorporating the proposed semiparamet-
ric component into a generalized linear modeling framework.
We may also consider genomic variables that are subject to
censoring or detection limits, as in the case of metabolomics
data (Yu et al. 2014). In this case, the conditional mean of
the genomic variable cannot be consistently estimated using
simple least-squares estimation, and additional assumptions on
the distribution of the genomic variable are necessary.
Second, it would be of interest to perform a joint test for
multiple genomic variables, where each variable may have a
separate pattern of missing values. This extension can be applied
to many existing testing procedures that involve a multivariate
score statistic, such as the sequence kernel association test for
rare variants (Wu et al. 2011), tests for meta-analysis of sequenc-
ing data (Tang and Lin 2013), and the joint test for multiple
genomic variables (Huang, VanderWeele, and Lin 2014). Joint
modeling of multiple variables with missing values is more
challenging than modeling a single variable with missing value,
when the pattern of the missing values for each variable do not
overlap. Nevertheless, fitting a separate imputation model for
each variable is not preferable, as it results in efficiency loss when
the variables are correlated.
Finally, we have assumed that the missing-data mechanism
depends only on the phenotype and a set of discrete covariates.
The methodology can be extended to allow the missing-data
mechanism to depend on continuous covariates by relating the
variable with missing values to a nonparametric function of
the phenotype and covariates. In addition, we may consider a
missing-data mechanism that depends on a different phenotype;
this scenario is common in the analysis of secondary pheno-
types. In this case, the function through which the covariates
affect the alternative phenotype must be estimated, and the vari-
able with missing values should be modeled nonparametrically
on that function.
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